[Long-term corticoid therapy in dermatology].
D000284:Administration, Oral; D002648:Child; D002940:Circadian Rhythm; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008599:Menstruation Disturbances / Q000139:chemically induced; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D010248:Paramethasone / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D012871:Skin Diseases / Q000188:drug therapy*; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000009:adverse effects / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D014222:Triamcinolone Acetonide; D010248:Paramethasone; D008775:Methylprednisolone
Corticoid-Langzeit therapie in der Dermatologie.